Altavista Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$755K Hold
2,734
0.15% 104
2021
Q3
$632K Sell
2,734
-66
-2% -$16.3K 0.14% 108
2021
Q2
$643K Buy
2,800
+50
+2% +$10K 0.14% 107
2021
Q1
$514K Hold
2,750
0.13% 113
2020
Q4
$464K Hold
2,750
0.12% 115
2020
Q3
$407K Hold
2,750
0.11% 114
2020
Q2
$451K Hold
2,750
0.13% 104
2020
Q1
$381K Buy
+2,750
New +$378K 0.13% 107
2019
Q4
Sell
-2,750
Closed -$308K 172
2019
Q3
$308K Hold
2,750
0.1% 135
2019
Q2
$305K Hold
2,750
0.1% 128
2019
Q1
$357K Hold
2,750
0.13% 114
2018
Q4
$318K Hold
2,750
0.13% 113
2018
Q3
$295K Hold
2,750
0.11% 126
2018
Q2
$235K Sell
2,750
-300
-10% -$24.6K 0.09% 133
2018
Q1
$236K Buy
+3,050
New +$246K 0.1% 133

Other funds holding LLY

Altavista Wealth Management's LLY Position: Q4 2021 in Review

Altavista Wealth Management held its Eli Lilly (LLY) position steady in Q4 2021 at 2,734 shares worth $755K. The position accounts for 0.15% of the portfolio, ranked #104.

Altavista Wealth Management first reported a position in LLY in Q1 2018 and has held it in 15 quarters since. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Altavista Wealth Management held 2,734 shares of Eli Lilly worth $755K as of Q4 2021.
  • Altavista Wealth Management left its Eli Lilly share count unchanged in Q4 2021.
  • Eli Lilly made up 0.15% of Altavista Wealth Management's portfolio in Q4 2021, its #104 holding.
  • Altavista Wealth Management first reported a position in Eli Lilly in Q1 2018 and has held it in 15 quarters since.
  • 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.